Related Experiment Video
Updated: Apr 3, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Emergence of Azole Resistance in Aspergillus
Nathan P Wiederhold1, Thomas F Patterson2
1Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Abstract:
Resistance to the azole antifungals itraconazole, voriconazole, and posaconazole in Aspergillus species is a growing concern. This is especially alarming for A. fumigatus, where acquired resistance has been documented in patients with invasive disease caused by this species that were exposed to these agents, as well as in azole-naive individuals. The primary mechanisms of resistance that have been described in clinical strains include different point mutations in the CYP51A gene, which encodes the enzyme responsible for converting lanosterol to ergosterol via demethylation. Some resistant isolates also contain a tandem repeat in the promoter region of this gene that causes increased expression. These mutations, including TR34/L98H and TR46/Y121F/T289A have also been found in the environment in several areas of the world and have been demonstrated to cause resistance to azole fungicides used in agriculture, thus raising the concern of environmental spread of resistance. Treatment options are limited in patients with infections caused by azole-resistant isolates and include amphotericin B formulations or combination therapy involving an echinocandin. However, there are few clinical data available to help guide therapy, and infections caused by resistant A. fumigatus isolates have been reported to have high mortality rates.
Insights
Azole antifungal resistance in Aspergillus species, particularly Aspergillus fumigatus, is increasing due to CYP51A gene mutations. This resistance poses a significant threat, with limited treatment options and high mortality rates for invasive infections.
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
- Molecular Biology
Background:
- Growing concern over azole antifungal resistance in Aspergillus species, impacting treatment efficacy.
- Acquired resistance documented in Aspergillus fumigatus, affecting both exposed patients and azole-naive individuals.
- Clinical and environmental emergence of azole-resistant Aspergillus strains worldwide.
Purpose of the Study:
- To summarize the mechanisms and implications of azole resistance in Aspergillus species.
- To highlight the clinical challenges and treatment limitations for infections caused by resistant strains.
- To underscore the environmental dissemination of resistance mechanisms.
Main Methods:
- Review of clinical and environmental data on azole resistance in Aspergillus.
- Analysis of genetic mutations in the CYP51A gene associated with resistance.
- Examination of resistance mechanisms including point mutations and promoter region alterations.
Main Results:
- Key resistance mechanisms involve point mutations in CYP51A (e.g., TR34/L98H, TR46/Y121F/T289A) and promoter tandem repeats.
- These mutations confer resistance to itraconazole, voriconazole, and posaconazole.
- Environmental detection of resistance mechanisms raises concerns about agricultural fungicide impact and spread.
Conclusions:
- Azole resistance in Aspergillus fumigatus is a significant clinical problem with limited therapeutic alternatives.
- High mortality rates are associated with invasive infections caused by azole-resistant A. fumigatus.
- Environmental spread of resistance necessitates further investigation and monitoring.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Related Concept Videos
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Antifungal Agents
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA